Skip to main content
MAXCYTE, INC. logo

MAXCYTE, INC. — Investor Relations & Filings

Ticker · MXCT ISIN · US57777K1060 LEI · 54930053YHXULRFCU991 US Professional, scientific and technical activities
Open in API
Filings indexed 767 across all filing types
Latest filing 2025-05-23 Major Shareholding Noti…
Country US United States of America
Listing US MXCT

About MAXCYTE, INC.

https://www.maxcyte.com/

MaxCyte, Inc. is a cell-engineering company that provides enabling platform technologies to advance the discovery, development, and commercialization of cell-based therapeutics. Its core offering is the ExPERT™ platform, which utilizes proprietary Flow Electroporation® technology for efficient, scalable, and non-viral transfection of complex cells. This technology supports a wide range of applications, including cell therapy, gene editing, antibody and protein production, and vaccine development. Additionally, MaxCyte offers SeQure™ genotoxicity assessment services to evaluate the safety of gene-edited products by detecting on- and off-target effects. The company employs a partnership-driven licensing model to support clients from early-stage research through to clinical and commercial manufacturing.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by BlackRock, Inc. regarding its shareholding in MaxCyte, Inc. This is a classic regulatory disclosure required when a shareholder crosses a specific ownership threshold. It follows the standard format for major shareholding notifications as defined by the FCA and the London Stock Exchange's RNS system.
2025-05-23 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by BlackRock, Inc. regarding its shareholding in MaxCyte, Inc. This is a classic regulatory disclosure document used when an investor crosses a specific ownership threshold in a publicly traded company. It fits the definition of a 'Major Shareholding Notification' (MRQ).
2025-05-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by BlackRock, Inc. regarding its shareholding in MaxCyte, Inc. This is a regulatory requirement for institutional investors to disclose when their voting rights cross specific thresholds. This document type is explicitly defined as a 'Major Shareholding Notification' (MRQ) in the provided classification schema.
2025-05-16 English
Filing of Form 10-Q
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 5,000 characters) from MaxCyte, Inc. stating that they have filed their Form 10-Q for the quarterly period ended March 31, 2025. It provides links to where the actual report can be found on the SEC website and the company's investor relations page. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, and therefore qualifies as a Report Publication Announcement (RPA).
2025-05-09 English
10-Q
Interim / Quarterly Report Q1 2025
2025-05-08 English
First Quarter 2025 Financial Results
Earnings Release Classification · 1% confidence The document is a press release from MaxCyte, Inc. announcing its financial results for the first quarter ended March 31, 2025. It includes key financial highlights, revenue breakdowns, management commentary, and future guidance. It is clearly an initial announcement of quarterly financial results, which fits the definition of an Earnings Release (ER). It is not a full quarterly report (IR) nor a report publication announcement (RPA), as it contains the actual financial data and highlights rather than just notifying of a report's availability. Q1 2025
2025-05-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.